BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 22954378)

  • 1. Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease.
    Saha S; Wald A
    Expert Opin Drug Saf; 2012 Nov; 11(6):947-57. PubMed ID: 22954378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
    McConnell RA; Mahadevan U
    Inflamm Bowel Dis; 2016 Jan; 22(1):213-23. PubMed ID: 26444103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Safety and Risk of Adverse Outcomes for Pregnant Patients With Inflammatory Bowel Disease.
    Mahadevan U; McConnell RA; Chambers CD
    Gastroenterology; 2017 Feb; 152(2):451-462.e2. PubMed ID: 27769809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biologics and pregnancy: a clinician's guide to the management of IBD in pregnant women.
    Guerrero Vinsard D; Kane SV
    Expert Rev Gastroenterol Hepatol; 2021 Jun; 15(6):633-641. PubMed ID: 33440996
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety of immunomodulators and biologics for the treatment of inflammatory bowel disease during pregnancy and breast-feeding.
    Gisbert JP
    Inflamm Bowel Dis; 2010 May; 16(5):881-95. PubMed ID: 19885906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: a decision-making algorithm for the management of pregnancy in the inflammatory bowel disease patient.
    Habal FM; Huang VW
    Aliment Pharmacol Ther; 2012 Mar; 35(5):501-15. PubMed ID: 22221203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates on the management of inflammatory bowel disease from periconception to pregnancy and lactation.
    Nielsen OH; Gubatan JM; Kolho KL; Streett SE; Maxwell C
    Lancet; 2024 Mar; 403(10433):1291-1303. PubMed ID: 38458222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation.
    Puchner A; Gröchenig HP; Sautner J; Helmy-Bader Y; Juch H; Reinisch S; Högenauer C; Koch R; Hermann J; Studnicka-Benke A; Weger W; Puchner R; Dejaco C
    Wien Klin Wochenschr; 2019 Jan; 131(1-2):29-44. PubMed ID: 30643992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exposure Concentrations of Infants Breastfed by Women Receiving Biologic Therapies for Inflammatory Bowel Diseases and Effects of Breastfeeding on Infections and Development.
    Matro R; Martin CF; Wolf D; Shah SA; Mahadevan U
    Gastroenterology; 2018 Sep; 155(3):696-704. PubMed ID: 29857090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IBD medications during pregnancy and lactation.
    Nielsen OH; Maxwell C; Hendel J
    Nat Rev Gastroenterol Hepatol; 2014 Feb; 11(2):116-27. PubMed ID: 23897285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of inflammatory bowel disease in the pregnant patient.
    Habal FM; Ravindran NC
    World J Gastroenterol; 2008 Mar; 14(9):1326-32. PubMed ID: 18322943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-TNF therapy in inflammatory bowel diseases during pregnancy and breast-feeding].
    Persić M
    Acta Med Croatica; 2013 Apr; 67(2):157-64. PubMed ID: 24471298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACOG Committee Opinion No. 776: Immune Modulating Therapies in Pregnancy and Lactation.
    Obstet Gynecol; 2019 Apr; 133(4):e287-e295. PubMed ID: 30913201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan.
    Naganuma M; Kunisaki R; Yoshimura N; Nagahori M; Yamamoto H; Kimura H; Sako M; Kawaguchi T; Takazoe M; Yamamoto S; Matsui T; Hibi T; Watanabe M
    J Crohns Colitis; 2011 Aug; 5(4):317-23. PubMed ID: 21683301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of medications during pregnancy and breastfeeding for Crohn's disease and ulcerative colitis.
    Laube R; Paramsothy S; Leong RW
    Expert Opin Drug Saf; 2021 Mar; 20(3):275-292. PubMed ID: 33412078
    [No Abstract]   [Full Text] [Related]  

  • 16. Pregnant women with IBD are more likely to be adherent to biologic therapies than other medications.
    Lee S; Seow CH; Adhikari K; Metcalfe A
    Aliment Pharmacol Ther; 2020 Mar; 51(5):544-552. PubMed ID: 31797416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pregnancy and inflammatory bowel disease: experience in 17 patients].
    Vergara A MT; Rey G P
    Rev Med Chil; 2011 Nov; 139(11):1421-7. PubMed ID: 22446646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy of inflammatory bowel disease in fertile women.
    Kroser J; Srinivasan R
    Am J Gastroenterol; 2006 Dec; 101(12 Suppl):S633-9. PubMed ID: 17177868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of inflammatory bowel disease in pregnancy.
    Vermeire S; Carbonnel F; Coulie PG; Geenen V; Hazes JM; Masson PL; De Keyser F; Louis E
    J Crohns Colitis; 2012 Sep; 6(8):811-23. PubMed ID: 22595185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuing immunomodulators and biologic medications in pregnant IBD patients - pro.
    Mahadevan U
    Inflamm Bowel Dis; 2007 Nov; 13(11):1439-40. PubMed ID: 17763475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.